Diabetes Monitoring Devices Market, by Product Type (Self-Glucose Monitoring Devices, and Continuous Glucose Monitoring Devices), by Indication (Type-I Diabetes, Type-II Diabetes, and Gestational Diabetes), by Approach (Invasive and Non-invasive), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Centers, and Self-Care), and by Region - Global Trends, and Forecast to 2025

  • Published On : Feb 2018 |
  • Pages : 205 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Diabetes Monitoring Devices Market – Pledging Towards a Diabetic Free World

Diabetes is referred as group of metabolic diseases wherein patient suffers from varying levels of glucose either due to inadequate production of insulin or due to irresponsiveness of body’s cells to respond to insulin. Symptoms of patients suffering from diabetes include frequent urination (polyuria), excessive hunger (polyphagia), and increased thirst (polydipsia). Diabetes can affect eyes, kidneys, nerves and other body parts wherein, the excessive blood glucose levels can result into progression of cardiovascular diseases leading to death of a person. Thus the treatment goal of diabetes is to control the blood sugar levels, which can be monitored and tracked using assistive medical devices known as diabetes monitoring or blood glucose monitoring devices. These devices are available for patients suffering from both type I and type II diabetes for regular glucose invigilation and secure oneself from threats associated with diabetes. High prevalence of diabetes due to changing lifestyle is increasing the demand for diabetes monitoring devices in developed as well as emerging economies, which in turn is propelling growth of the market.

The global Diabetes Monitoring Devices Market was valued at US$ 15,276.1 million in 2016 and is expected to witness a robust CAGR of 8.87% over the forecast period (2017 - 2025).

Figure 1. Global Diabetes Monitoring Devices Market (US$ Mn), by Region, 2016

diabetes monitoring devices market

US$ 5,545.22 Mn

Source: Coherent Market Insights (2018)

An extensive patient pool serves as a major driving factor for the diabetes monitoring devices market

Increasing incidence of diabetes across the world is one of the primary factor responsible to drive growth of the global diabetes monitoring devices market. For instance, according to the World Health Organization (WHO), 2014, around 8.5% of adults aged 18 and above accounting for 422 million adults were suffering from diabetes worldwide. Moreover, diabetes was the cause of 1.6 million deaths in 2015 and high blood glucose levels was the cause of another 2.2 million deaths. According to National Diabetes Statistics Report 2017 published by Centers of Disease Control and Prevention (CDC), around 9.4% of American population, which includes all age groups i.e., pediatric, adults and geriatric population accounting for 30.3 million people are suffering from diabetes whereas 33.9% of the rest population is diagnosed with pre-diabetes. The prevalence of diabetes is significant among the emerging economies of Asia. According to a study report published in World Journal of Diabetes 2012, Asian economies contribute to more than 60% of the diabetic population in the world. The massive prevalence of diabetes is thus expected to create a demand for monitoring blood glucose devices, which in turn is expected to foster growth of the global diabetes monitoring devices market.

Glucose monitoring devices are gaining significant traction due to increasing awareness among urban population regarding advantages of glucose monitoring. For instance, a research article published in Annals of Palliative Medicine- an Open Access Journal for High Quality Research 2015, suggested that the incidence of blood glucose monitoring practices was common among 19% of the people suffering with diabetes in Canada. Furthermore, increasing number of obese population is one of the major factors leading to rise in diabetes incidence. For instance, according to National Health and Nutrition Examination Survey 2014 conducted by National Institute of Diabetes and Digestive and Kidney Diseases, more than 1 among 3 adults suffering from Diabetes in the U.S. were reported to be overweight and more than 2 in 3 adults were considered to be overweight and obese.

However, high cost of easy operating automatic glucose monitoring and other devices, pricing pressure on manufacturers, and discrepancy in reimbursement policies are expected to hinder the market growth. On the contrary, increasing efforts by healthcare authorities and medical insurance companies to educate patients regarding the advantages of diabetes monitoring devices can create potential opportunities for growth of the market.

North America accounts for highest share in the global diabetes monitoring devices market, owing to government initiatives undertaken for the prevention of diabetes and treatment support coupled with presence of leading players in the region and advanced technical implementation in drug discovery procedures. For instance, in April 2017, the Centers of Disease Control and Prevention (CDC) released a five year funding opportunity announcement to scale up the National Diabetes Prevention Program in underserved areas of the country. Moreover, the CDC’s Division of Diabetes Translation (DDT) funds state and local health departments to support programs and activities for improving health outcomes in people suffering from diabetes. Asia Pacific is expected to witness a significant growth over the forecast period, owing to increasing incidence of diabetic patients as well as development of cost-effective diabetes monitoring devices to cater the local population. For instance, according to the World Health Organization (WHO), 2017, the South-East Asian region has an estimated 96 million people suffering from diabetes, which creates high demand for blood glucose monitoring devices and medical therapies, which in turn is fueling the market growth.

Advancements in the glucose monitoring devices to boost growth of the global market

Market players are actively investing into research for developing innovative solutions by integrating units to monitor the insulin levels and maintain the blood glucose levels by automatically delivering insulin to parts of the body with the help of continuous glucose monitoring systems. For instance, in September 2017, the U.S. FDA approved first blood sugar monitor that does not require finger pricks and uses a small sensor that can be attached to the upper arm for continuous glucose monitoring. Moreover, in February 2018, Medtronic Plc introduced a next generation continuous glucose monitoring system named iPro 2 Professional to improve diabetes management in 41 economies around the world.

The key players operating the global diabetes monitoring devices market include Bayer Healthcare AG, Medtronic, Dexcom, Sanofi, Abbott Laboratories, MediWise, Arkay, Inc., Cnoga Medical, and Bigfoot Biomedical.

Diabetes refers to a group of metabolic diseases in which a person suffers from high or low levels of blood sugar levels for a prolonged period. Most common symptoms of diabetes includes increased thirst, increased urination, and increased hunger. Diabetes is one the prime diseases that carries risk of chronic cardiovascular diseases and can also lead to life-threatening events such as cardiac arrests or heart failure. Thus, it is a preliminary requirement for diabetic patient to monitor blood glucose levels at frequent time intervals, which can be achieved by diabetes monitoring devices.

Market Dynamics

The major factors contributing the growth of global diabetes monitoring devices market are increasing number of patients suffering from diabetes across the world. According to the World Health Organization (WHO) 2014, diabetes is one of the diseases that has dire consequences on health, which affected around 422 million people across the world in 2014. Moreover, it has resulted in approximately 1.6 million deaths in 2015, which increases the demand for management solutions. Moreover, obesity is one of the other prominent factor that leads to the cause of diabetes in most of the obese patients. According to The National Institute of Diabetes and Digestive and Kidney Diseases, Statistics on Diabetes 2015, over 90% of patients suffering from diabetes were reported to be obese. However, the high cost of these devices coupled with the calibration errors associated with these devices are hindering the market growth. The research and development in the area of continuous glucose monitors are expected to provide growth opportunities for new and established market players to capitalize upon and witness growth in terms of sales, as these devices are in high demand due to the hassle free diabetes monitoring records that they provide in real time at a go.

Key features of the study:

  • This report provides in-depth analysis of diabetes monitoring devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global diabetes monitoring devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study Bayer Healthcare AG, Medtronic, Dexcom, Sanofi S.A., Roche Diagnostics, Johnson & Johnson, Abbott Laboratories, MediWise, Arkay, Inc., Cnoga Medical, and Bigfoot Biomedical.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global diabetes monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the diabetes monitoring devices market

Detailed Segmentation:

  • Global Diabetes Monitoring Devices Market, By Product Type:
    • Self-Monitoring Glucose Devices
    • Continuous Glucose Monitoring Devices
  • Global Diabetes Monitoring Devices Market, By Indication:
    • Type-I Diabetes
    • Type-II Diabetes
    • Gestational Diabetes
  • Global Diabetes Monitoring Devices Market, By Approach:
    • Invasive
    • Non-Invasive
  • Global Diabetes Monitoring Devices Market, By End User:
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Home Care Centers
    • Others
  • Global Diabetes Monitoring Devices Market, By Geography:
    • North America
      • By Product Type:
        • Self-Monitoring Glucose Devices
        • Continuous Glucose Monitoring Devices
      • By Indication:
        • Type-I Diabetes
        • Type-II Diabetes
        • Gestational Diabetes
      • By Approach:
        • Invasive
        • Non-Invasive
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Home Care Centers
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Self-Monitoring Glucose Devices
        • Continuous Glucose Monitoring Devices
      • By Indication:
        • Type-I Diabetes
        • Type-II Diabetes
        • Gestational Diabetes
      • By Approach:
        • Invasive
        • Non-Invasive
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Home Care Centers
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Self-Monitoring Glucose Devices
        • Continuous Glucose Monitoring Devices
      • By Indication:
        • Type-I Diabetes
        • Type-II Diabetes
        • Gestational Diabetes
      • By Approach:
        • Invasive
        • Non-Invasive
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Home Care Centers
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Self-Monitoring Glucose Devices
        • Continuous Glucose Monitoring Devices
      • By Indication:
        • Type-I Diabetes
        • Type-II Diabetes
        • Gestational Diabetes
      • By Approach:
        • Invasive
        • Non-Invasive
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Home Care Centers
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Self-Monitoring Glucose Devices
        • Continuous Glucose Monitoring Devices
      • By Indication:
        • Type-I Diabetes
        • Type-II Diabetes
        • Gestational Diabetes
      • By Approach:
        • Invasive
        • Non-Invasive
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Home Care Centers
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Self-Monitoring Glucose Devices
        • Continuous Glucose Monitoring Devices
      • By Indication:
        • Type-I Diabetes
        • Type-II Diabetes
        • Gestational Diabetes
      • By Approach:
        • Invasive
        • Non-Invasive
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
        • Home Care Centers
        • Others
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Bayer AG *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Roche Diagnostics
    • Johnson & Johnson
    • Medtronic plc
    • Dexcom, Inc.
    • Abbott Laboratories Ltd.
    • MediWise
    • Arkay, Inc.
    • Cnoga Medical
    • Bigfoot Biomedical
    • Sanofi S.A.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Indication
      • Market Snippet, By Approach
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Key Highlights
    • Reimbursement Scenario
    • Technological Advancements
    • Recent FDA Approvals
    • FDA Guidelines for Diabetes Monitoring Devices Market
    • Epidemiology
  4. Global Diabetes Monitoring Devices Market, By Product Type, 2017 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Self-Monitoring Blood Glucose Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
    • Continuous Glucose Monitoring Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
  5. Global Diabetes Monitoring Devices Market, By Indication, 2017 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Type-I Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
    • Type-II Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
    • Gestational Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
  6. Global Diabetes Monitoring Devices Market, By Approach, 2017 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Invasive
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
    • Non-Invasive
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
  7. Global Diabetes Monitoring Devices Market, By End User, 2017 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
    • Home Care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
  8. Global Diabetes Monitoring Devices Market, By Region, 2017 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Region, 2016 – 2025
    • North America
      • Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Indication, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Approach, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Indication, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Approach, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Indication, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Approach, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Indication, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Approach, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Indication, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Approach, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Indication, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Approach, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By End User, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • Bayer AG*
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments
        • Strategies
      • Roche Diagnostics
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments
        • Strategies
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments
        • Strategies
      • Medtronic plc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments
        • Strategies
      • Dexcom, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments
        • Strategies
      • Abbott Laboratories
        •  Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments
        • Strategies
      • MediWise
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments
        • Strategies
      • Arkay, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments
        • Strategies
      • Cnoga Medical
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments
        • Strategies
      • Bigfoot Biomedical
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments
        • Strategies
      • Sanofi
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments
        • Strategies
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 42 market data tables and 24 figures on "Diabetes Monitoring Devices Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.